ZIMMER BIOMET HOLDINGS, INC. 10-Q

Item 2. Unregistered Sales of Equi ty Securities and Use of Proceeds Unregistered Sales of Equity Securities During the three-month period ended March 31, 2025, we issued 0.3 million shares of our common stock valued at $27.8 million upon the achievement of a commercial milestone related to the Embody acquisition. The shares were issued to the former Embody shareholders whom we reasonably believed to be accredited investors in a private transaction exempt from registration under Section 4(a)(2) and Regulation D under the Securities Act. Issuer Purchases of Equity Securities The following table summarizes repurchases of common stock settled during the three-month period ended March 31, 2025: Period Total Number of Shares Purchased Average Price Paid per Share Total Number of Shares Purchased as a Part of Publicly Announced Program (1) Maximum Approximate Dollar Value of Shares that may yet be Purchased Under the Program (1) January 2025 - $ - - $ 1,249,999,420 February 2025 837,755 103.27 837,755 1,163,483,012 March 2025 1,322,553 108.32 1,322,553 1,020,224,454 Total 2,160,308 $ 106.36 2,160,308 1,020,224,454 (1) In May 2024, our Board of Directors authorized a $2.0 billion share repurchase program with no expiration date. Item 3. Defaults Upo n Senior Securities None Item 4. Mine Saf ety Disclosures Not applicable